Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fasting Conditions
Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to determine and compare the rate and extent of absorption of
norethindrone and unconjugated estradiol from a test formulation of Estradiol/Norethindrone
Acetate Tablets, 1 mg/0.5 mg versus the reference Activella® (1 mg estradiol/0.5 mg
norethindrone acetate) Tablets under fasting conditions.